From Bioblast
FR Bordeaux Rossignol R
| O2k-Network Lab | INSERM-EMI 9929
Université Victor Segalen |
|---|---|
| Address | 146, rue Léo Saignat, 33076 |
| City | Bordeaux |
| State/Prov | |
| Country | France |
| Weblink | |
| Contact | Rossignol Rodrigue, Amoedo Nivea D |
| Team | Bellance Nadege, Gutierrez Cortes Nicolas, Mazat Jean-Pierre, Saharnaz Sarlak |
| Team previous | Jose Caroline |
| Status | 2 Power-O2k 2003- |
| Oroboros Events | IOC137, MiP2015, MiP2014, MiP2013, Bioblast 2012, IOC72, IOC54, IOC39, IOC23, IOC13 |
| Topics |
O2k-Publications
| Published | Reference | |
|---|---|---|
| Amoedo 2021 J Clin Invest | 2021 | Amoedo ND, Sarlak S, Obre E, Esteves P, Bégueret H, Kieffer Y, Rousseau B, Dupis A, Izotte J, Bellance N, Dard L, Redonnet-Vernhet I, Punzi G, Rodrigues MF, Dumon E, Mafhouf W, Guyonnet-Dupérat V, Gales L, Palama T, Bellvert F, Dugot-Senan N, Claverol S, Baste JM, Lacombe D, Rezvani HR, Pierri CL, Mechta-Grigoriou F, Thumerel M, Rossignol R (2021) Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas. J Clin Invest 131:e133081. |
| Bastos Sant'Anna Silva 2021 Cancers (Basel) | 2021 | Bastos Sant'Anna Silva AC, Perez Valencia JA, Sciacovelli M, Lalou C, Sarlak S, Tronci L, Nikitopoulou E, Meszaros AT, Frezza C, Rossignol R, Gnaiger E, Klocker H (2021) Succinate anaplerosis has an onco-driving potential in prostate cancer cells. Cancers 13:1727. https://doi.org/10.3390/cancers13071727 |
| Esteves 2019 Oncogene | 2019 | Esteves P, Dard L, Brillac A, Hubert C, Sarlak S, Rousseau B, Dumon E, Izotte J, Bonneu M, Lacombe D, Dupuy JW, Amoedo N, Rossignol R (2019) Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F. Oncogene 39:617-36. |
| Szelechowski 2018 Sci Rep | 2018 | Szelechowski M, Amoedo N, Obre E, Léger C, Allard L, Bonneu M, Claverol S, Lacombe D, Oliet S, Chevallier S, Le Masson G, Rossignol R (2018) Metabolic reprogramming in amyotrophic lateral sclerosis. Sci Rep 8:3953. |
| Jose 2018 Redox Biol | 2018 | Jose C, Hebert-Chatelain E, Dias Amoedo N, Roche E, Obre E, Lacombe D, Rezvani HR, Pourquier P, Nouette-Gaulain K, Rossignol R (2018) Redox mechanism of levobupivacaine cytostatic effect on human prostate cancer cells. Redox Biol 18:33-42. |
| Rodrigues 2016 Biochem J | 2015 | Rodrigues MF, Obre E, Melo FH, Santos-Jr GC, Galina A, Jasiulionis MG, Rossignol R, Rumjanek FD, Amoedo ND (2016) Enhanced OXPHOS, glutaminolysis and beta-oxidation constitute the metastatic phenotype of melanoma cells. https://doi.org/10.1042/BJ20150645 |
| Jose 2012 Thesis | 2012 | Jose C (2012) Rôle des mitochondries dans la tumorigénèse: implications pour le traitement du cancer. PhD Thesis 272. |
| Smolkova 2010 J Bioenerg Biomembr | 2010 | Smolková K, Bellance N, Scandurra F, Génot E, Gnaiger E, Plecitá-Hlavatá L, Ježek P, Rossignol R (2010) Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia. J Bioenerg Biomembr 42:55-67. https://doi.org/10.1007/s10863-009-9267-x |
| Bellance 2009 Int J Biochem Cell Biol | 2009 | Bellance N, Benard G, Furt F, Begueret H, Smolková K, Passerieux E, Delage JP, Baste JM, Moreau P, Rossignol R (2009) Bioenergetics of lung tumors: Alteration of mitochondrial biogenesis and respiratory capacity. Int J Biochem Cell Biol 41:2566-77. |
O2k-Abstracts
| Published | Reference | |
|---|---|---|
| Amoedo 2015 Abstract MiP2015 | 2015 | The energy requirement of metastatic cells. |
| Rodrigues 2014 Abstract MiP2014 | 2014 | Bioenergetics’ traits of tongue cancer metastatic cells. |
Bioblast alert
